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Abstract
Representing and analyzing complex networks remains a roadblock to creating dynamic network models of biological
processes and pathways. The study of cell fate transitions can reveal much about the transcriptional regulatory programs
that underlie these phenotypic changes and give rise to the coordinated patterns in expression changes that we observe.
The application of gene expression state space trajectories to capture cell fate transitions at the genome-wide level is one
approach currently used in the literature. In this paper, we analyze the gene expression dataset of Huang et al. (2005) which
follows the differentiation of promyelocytes into neutrophil-like cells in the presence of inducers dimethyl sulfoxide and all-
trans retinoic acid. Huang et al. (2005) build on the work of Kauffman (2004) who raised the attractor hypothesis, stating
that cells exist in an expression landscape and their expression trajectories converge towards attractive sites in this
landscape. We propose an alternative interpretation that explains this convergent behavior by recognizing that there are
two types of processes participating in these cell fate transitions—core processes that include the specific differentiation
pathways of promyelocytes to neutrophils, and transient processes that capture those pathways and responses specific to
the inducer. Using functional enrichment analyses, specific biological examples and an analysis of the trajectories and their
core and transient components we provide a validation of our hypothesis using the Huang et al. (2005) dataset.
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Introduction
Our understanding of the molecular basis of a wide range of
biological processes, including development, differentiation, and
disease, has evolved significantly in recent years. Increasingly, we
are coming to recognize that it is not single genes, but rather
complex networks of genes, gene products, and other cellular
elements that drive cellular metabolism and cell fate, and when
perturbed, can lead to development of disease phenotypes.
Representing and analyzing such complex networks, encompass-
ing thousands or tens of thousands of elements, presents signifi-
cant challenges. One approach that has begun to be applied is
the representation of transcriptional changes as transitions that
occur with the ‘‘state space’’ defined by the expression states of all
genes within the cell [1,2]. This approach has a number of
advantages, including providing a framework for predictive mode-
ling and the incorporation of stochastic components in the
biological process.
The underlying assumption in such an analysis is that each
cellular phenotype can invariably be traced back to a particular
class of genome-wide gene expression signatures representing a
specific region of the gene expression state space. As described in
Huang et al. [3], this signature for a particular cellular state at a
particular instant in time is represented by a multidimensional
gene expression vector in a high dimensional space where each
coordinate represents the expression level of a particular gene. By
considering all possible configurations that this signature can take,
we create a multidimensional landscape that is referred to as the
expression state space [1]. Each observed phenotype can be
represented as a single point in the state space. When cells
transition through successive phenotypes, for example, during the
different stages of hematopoietic differentiation, specific sets of
genes alter their expression levels as dictated by an underlying
transcriptional program and these changes can be represented by
a continuous trajectory in expression state space; ultimately these
represent the transcriptional program being played out by the
cell’s collection of gene networks and complex pathways.
Kauffman [1] first proposed the idea that stable cell fates, the
cellular phenotypes we observe, correspond to ‘‘attractors’’ in the
expression state space, stable points to which the system would
return to if subjected to a small perturbation. He points out that in
principle cells could adopt any permutation of gene expression
states (as many as the number of genes and as infinite as the
number of expression level states) however this is not what we
observe in nature. According to Kauffman, since there are about
250 different cell types, there must be approximately that number
of attractors in state space, either valleys or peaks in the landscape,
that represent the stable cell fates or cell types that cells will
ultimately converge to in the presence of an inducer or
perturbation. While this is an interesting model, direct experi-
mental evidence supporting it and its overall utility in explaining
cellular mechanism remain to be seen.
PLoS Computational Biology | www.ploscompbiol.org 1 December 2009 | Volume 5 | Issue 12 | e1000626Huang et al. [3] reported evidence they claim demonstrated the
existence of an attractor. They conducted a gene expression time-
course experiment on the differentiation of human HL-60
promyelocytic cells into neutrophils using two different inducers,
dimethyl sulfoxide (DMSO) and all-trans retinoic acid (ATRA).
Time-course data was collected using Affymetrix U95Av2
GeneChips and analyzed to provide gene expression level
measures necessary to create a state-space model. Using principal
components analysis, they develop a two-dimensional state space
representation in which DMSO and ATRA induce initially
divergent trajectories that, over time, converge on a common
trajectory leading to a final expression state representing the
neutrophils. They argue that instead of observing trajectories that
explore the state space, the trajectories display convergence to a
single point and that this therefore provides empirical proof that
attractive states exist in nature.
Here, we propose an alternative interpretation of this
convergent behavior that does not appeal to the attractor
hypothesis but rather explores this observation in the context of
a superposition of components that reflect the pathways activated
by the applied perturbations. To this end, we extend the work of
Huang et al. [3] by decomposing the state space trajectories into
components comprising two sets of genes, a core group and
transient group that capture the stimulus-independent and
stimulus-dependent effects, respectively. The superposition of
these components reflect the observation that both sources of
effects independently influence the overall shape of the trajectory
taken during the cell fate transition. We show how this division
allows us to look at functional behavior of genes and their
contribution to the cell fate transitions in a more enlightening way.
Using regression models, we isolate core genes that are common to
both stimuli and represent those critical to the differentiation
process. The genes outside the core represent the transient
component of the trajectory corresponding to the perturbation
effects. To illustrate our ideas, we apply our method to the same
published dataset generated by Huang et al. [3].
The HL-60 cell line has long been used as a model to
understand the molecular mechanisms driving the progression and
pathogenesis of acute promyelocytic leukemia (APL) [4]. In
normal promyelocytes, proliferation and differentiation are tightly
coupled processes. However this balance comes unstuck in APL
cells and as a result cells proliferate in a disregulated fashion. The
discovery that inducers like RA and DMSO could reprogram APL
cells to overcome this block and resume differentiation, led to the
emergence of a class of therapeutics known as differentiation
therapy [5].
DMSO is an organic solvent but also functions as a
cryoprotective agent for tissue cell culture [4]. Although it is
widely used in veterinary medicine in the treatment of pain and
inflammation, it is not generally used in humans because it is
known to be hepatotoxic. The hormone ATRA is a derivative of
vitamin A and belongs to a class of molecules called retinoids [6].
ATRA is currently used in differentiation therapies that treat
human patients with APL. Current complete remission rates for
APL patients on ATRA-based differentiation therapy in combi-
nation with chemotherapy have been reported to be as high as 90–
95% [7]. At the molecular level, both DMSO and ATRA arrest
the cell cycle at the G1-S phase transition point, and induce
terminal differentiation of HL-60 cells, resulting in neutrophil-like
cells.
ATRA and DMSO are biochemically distinct molecules that
activate slightly different sets of pathways in HL-60 cells. Huang
et al. [3] explain that this is the reason why the trajectories initially
diverge and explore different parts of the expression state space.
They argue that it is the presence of an attractor that then causes
the trajectories to converge from different directions to eventually
arrive at a common endpoint, and discount the possibility of a
‘‘specific, unique differentiation pathway’’ that may be triggered
by both inducers.
While this argument may seem conceptually appealing, upon
further inspection the attractor hypothesis greatly limits our ability
to develop mechanistic interpretations or to build predictive
models of cell fate transitions. We believe that there exists an
alternative, more plausible interpretation that Huang et al. [3] and
Kauffman [1] have not considered. Our interpretation is based on
the recognition that there are two types of processes that
contribute to cell fate transitions: one, a core biological process
inherent to the transition-specific event and two, a transient
process related to the direct effects that the particular inducing
agent exerts on the cell. The early divergence seen in the state
space trajectories described by Huang et al. [3] is reflective of the
cells’ response to specific perturbation and the compound-specific
response that follows. We expect these transient processes to
dominate only at the initial period of the time-course since most
drugs are metabolized quickly by the cell. Once this disorder has
subsided, the targeted effects of each inducer are expected to have
begun triggering the core processes and as this occurs, the
directions that both trajectories adopt become more and more
convergent because the overlap in activated pathways in DMSO-
induced cells and ATRA-induced cells is growing larger as the cells
transition towards their common endpoint. The source of this
convergence therefore is not necessarily due to the existence of an
attractor but instead can be explained by the combination of these
two types of processes exerting their temporal effects on cells.
Indeed, if such an attractor existed, then there should be a whole
class of perturbations that would cause transitions from the initial
to the final state, rather than a small number that activate a single
core pathway. If one adopts the attractor hypothesis as the basis
for cell-fate transitions, then our interpretation is much closer to
that of Conrad Waddington, in which he argued for the
‘‘canalization’’ of state space through the existence of defined
paths, or canals, between attractor states [8–10].
Author Summary
Understanding how cells differentiate from one state to
another is a fundamental problem in biology with
implications for better understanding evolution, the
development of complex organisms from a single fertilized
egg, and the etiology of human disease. One way to view
these processes is to examine cells as ‘‘complex adaptive
systems’’ where the state of all genes in a cell (more than
20,000 genes) determines that cell’s ‘‘state’’ at a given
point in time. In this view, differentiating cells move along
a path in ‘‘state space’’ from one stable ‘‘attractor’’ to
another. In a 2005 paper, Sui Huang and colleagues
presented an experimental model in which they claimed to
have evidence for such attractors and for the transitions
between them. The problem with this approach is that
although it is intuitively appealing, it lacks predictive
power. Reanalyzing Huang’s data, we demonstrate that
there is an alternative interpretation that still allows for a
state space description but which has greater ability to
make testable predictions. Specifically, we show that these
abstract state space trajectories can be mapped onto more
well-known pathways and represented as a ‘‘core’’
differentiation pathway and ‘‘transient’’ processes that
capture the effects of the treatments that initiate
differentiation.
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Preprocessing of the Gene Expression Time-Course
Dataset
The Affymetrix U95Av2 GeneChips used by Huang et al. [3]
gave an original dataset with approximately 12, 600 genes,
measured at twelve time points: two hours, four hours, eight
hours, twelve hours, eighteen hours, one day, two days, three
days, four days, five days, six days, seven days post-stimulation
with ATRA and DMSO. Filters were applied to this dataset to
remove genes that were associated with low expression or did
not show significant expression changes across the time points
measured. 3841 genes were retained by this filtering process.
The expression measures in the dataset provided by Huang
et al. [3] are represented as normalized log2 expression ratio
values where each gene’s ratio is formed by comparing its
expression measure in the stimulated time-course to its
corresponding expression in a non-stimulated control sample
of HL-60 cells.
In addition to the preprocessing steps already taken by Huang et
al. [3], it was necessary to remove genes that were considered flat,
that is genes that showed no change in their expression profiles
across the entire duration of the experiment for both inducers.
Since these genes clearly do not play a regulatory role in the
differential transcriptional program, it was necessary to remove
them from our analyses because their inclusion would only dilute
out meaningful results. Given that there were twelve time points
available, we fitted a cubic polynomial regression model separately
for each gene’s expression profile under each stimulus. For
example, for a single gene:
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represent random Normal
residual error terms.
A gene was discarded if both models (under DMSO and ATRA)
were not significant at the 0.05 level. Using this approach, 951
genes were filtered out from a starting total of 3841 genes.
It is worth nothing that the model fit for some expression
profiles might be improved by using polynomial regression models
of higher order than the cubic model we have adopted. However
this also represents an additional layer of parameter estimation,
and for reasons of parsimony we have applied only the cubic
model for all genes in our dataset.
Dividing Genes into Mutually Exclusive Groups Based on
their Role in the Cell Fate Transitions
O u ra n a l y s i si sb a s e do nt h es i m p l eh y p o t h e s i sr e g a r d i n gt h e
state space trajectories governing the observed cell fate
transition, namely that any observed trajectory can be
decomposed into two independent parts (see Figure 1); one
component represents the changes inherent to the specific
biological process driving the cell fate transitions (e.g. differen-
tiation of promyelocytes) and the other component captures the
t r a n s i e n te f f e c t so ft h ec e l l ’ sd i r ect response to the perturbation
(e.g. metabolism of DMSO or ATRA). We use the terms core
group and transient group to distinguish these two sets
respectively.
Based on this hypothesis, one should be able to define the set of
core genes based on comparison of expression profiles under
different stimuli. The core genes are those response genes that are
in common between stimuli and which are highly correlated. The
assumption is that such genes represent the specific differentiation
pathways carrying the cells between their initial and final states.
Expression profiles of a core gene are therefore expected to be
fairly robust for different perturbations. Similarly, the transient
genes are those which differ between the two stimuli and which
likely represent the metabolic processing of the stimulating agent,
as well as any short-term changes induced by stimuli unrelated to
changing the cell fate. Identifying these genes simply requires
identifying those genes with altered patterns of expression but
which are not well correlated between stimuli.
The formation of core and transient groups is based on a data-
driven classifier that is applied to the time-course gene expression
data. Our classification scheme begins first by fitting cubic
regression models to each individual gene expression profile. A
cubic model was chosen for this dataset because of the moderately
large number of time points available to fit a model with four to
eight covariates. For a single gene, both a full model and a reduced
model are fitted to its time-course expression profiles for each
perturbation. The full model specifies a set of parameters that
capture the time-dependent curvature of a gene’s expression
profile for each separate perturbation. In this way, the full model
assumes that the expression profile is different across the two
perturbations.
For a single gene, the full model is specified by the following
formulae, where Ya,b denotes the gene expression value measured
for inducer a at time point b:
Figure 1. Schematic diagram outlining our hypothesis.
doi:10.1371/journal.pcbi.1000626.g001
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represents a random Normal
residual error term.
The parameters a0, a1, a2, a3 and b0, b1, b2, b3 are the
coefficients of the time covariate in the model for the ATRA-
induced and DMSO-induced time series respectively. We
interpret these parameters in the following way: a0 represents
the gene’s expression in the ATRA-induced time series at time
zero, a1 represents the linear time effect on the gene’s
expression in the ATRA-induced time series, similarly a2 and
a3 represent the quadratic and cubic time effects, respectively.
Essentially these parameters measure the effect that the time
component has on a gene’s expression level, and we allow for
the possibility of time having a polynomial effect up to degree
three.
The reduced model is a simpler model that assumes the
expression profiles for different perturbations need only be
specified by the one set of parameters.
For a single gene, the reduced model is specified by the
following formulae:
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as defined in the full model.
Fitting these two models to a single gene, is equivalent to
proposing two hypotheses: one, that this gene belongs in the core
group and is therefore defined by the reduced model, and two, this
gene belongs in the transient group and is defined by the full
model. To decide which of these two hypotheses is more plausible
given the available data, we use the analysis of deviance test, which
is an extension of the likelihood ratio test.
The likelihood ratio statistic calculates the likelihood function (in
other words how well the data fits a hypothesized model) under
two different hypotheses and evaluates how statistically significant
the difference between the two likelihood functions is.
The likelihood ratio statistic L(x)t a k e st h ef o r mo f :
L x ðÞ ~
sup L hjx ðÞ : h [ V0 fg
sup L hjx ðÞ : h [ V fg
where V0~ l0,l1,l2,l3 ðÞ represents
the parameters specified under the null hypothesis that the gene
belongs in the core group and its profile is explained by our reduced
model.
The second vector V~ a0,a1,a2,a3,b0,b1,b2,b3 ðÞ represents the
parameters specified under the alternative hypothesis that the gene
belongs in the transient group and is therefore is specified by the
full model.
L(h | x) is the likelihood function specified by the model. The
numerator of L(x) represents this likelihood function calculated
under the reduced model (the core gene hypothesis), we use the
data to find the estimates of the unknown parameters that
maximize this likelihood.
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The statistic -2log2[L(x)] is asymptotically distributed as a Chi-
square random variable with four degrees of freedom. Therefore
at the 0.05 level of significance, if this statistic is greater than 3.841,
this implies that the difference between the two likelihoods is
significant and the full model has a higher likelihood, given the
expression profile data available. A gene with this result would
hence be placed in the transient group.
An extension of this test is the analysis of deviance, which
instead compares the size of the likelihood ratio statistic with the
likelihood of the full model alone. Because the full model specifies
more parameters, it follows that the likelihood of the full model
will be higher than the likelihood under the reduced model. What
we are interested in testing then is whether the improvement in the
model fit obtained with the full model over the reduced model is
statistically significant.
The analysis of deviance uses the ratio of the likelihood ratio
statistic and the likelihood under the full model only. This ratio
statistic is distributed as an F random variable with 4 and 16
degrees of freedom. The rationale is that when the full model
Decomposition of State Space Trajectories
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ratio statistic will be very large and hence the P-value will be very
small. This suggests that the full model significantly improves the
model fit to the expression profile data and the associated gene will
be classified as a transient gene. For more details on how the
likelihood ratio statistic and the analysis of deviance are computed
from the data, please see Text S1 [11].
Because our method involves testing almost three thousand
hypothesis tests, the chance of detecting a false positive result grows
to a non-trivial degree, for example at the 0.05 level, we expect to
declare about 144 transient genes purely by chance. To correct
against this, the resulting P-values must be adjusted for multiple
testing. We have chosen to adjust our P-values using the Benjamini-
Hochberg method which controls the false discovery rate [12].
Genes with significant adjusted P-values (less than 0.1) are placed in
the transient group; all other genes are in the core group. For the
Huang et al. dataset, this classification scheme identified 1428 core
genes and 1462 transient genes (see Tables S1 and S2) [11].
One limitation of this modeling approach is that for some genes,
there is a low degree of similarity between the observed expression
profile and the one predicted by the most appropriate model (see
Figure S1) [11]. This is especially the case for genes that display
spiky expression profiles across the time series. This is partly due to
the low degree of temporal sampling of what is a complex dynamic
system but also in part due to potential biological differences in the
samples themselves. It is possible that other curve-fitting methods
such as a Fourier transform or spline-dependent algorithm might
also be applicable to this kind of data. However these methods do
not provide the statistical machinery that comes with the regression
modeling approach that we have taken. The main advantage of our
method is being able to easily apply valid statistical tests to
determine which one of two models is more likely in light of the
data. We are also able to explicitly define statistical significance in a
meaningful way that protects against a specified false discovery rate.
Functional Enrichment Analysis
Our interpretation of the convergent behavior seen in the
expression states of cell fate transitions hinges on the assumption
that genes can be divided into a core or transient group, based on
their functional role in the cell fate transition. For this assumption
to be valid, we would therefore expect the genes in the core group
to be involved in processes related to the differentiation of
promyelocytes. Similarly, the transient group is expected to have
genes involved in processes related to the metabolism of the
inducer and a general response to the exposure of a foreign
stimulus. To investigate whether there is any evidence in the data
to support our assumptions, the core and transient groups were
subjected to a representation analysis using their GO term
assignments. The Gene Ontology Project [13] attempts to classify
gene products, assigning proteins to groups specifying their
Molecular Function, the Biological Process to which they
contribute, and their Cellular Component [14]. The GO terms
in each class form a hierarchy of increasing specificity (formally a
directed acyclic graph or DAG) so that the broadest classifications
provide a general picture of the functional class to which a gene
belongs (for example, a kinase) while more precise terms will
specify precisely what a particular gene does (such as specifying the
substrate on which a kinase acts). Functional category over-
representation was assessed using the Fisher’s exact test with a
Benjamini-Hochberg correction to adjust for multiple testing; P-
values were retained at the 0.1 significance level.
We identified 13 GO functional classes that were over-
represented in the core group, relative to the transient group.
All of these classes were associated with transcription and RNA
metabolism (see Table 1). These results support our assumption
that the genes in the core group are associated with a common
differentiation process. This can be seen by considering the over-
enrichment of GO categories for transcription, and transcriptional
regulation. During differentiation, cells require increased access to
a diverse range of proteins to transform themselves into new cell
types. The synthesis of these proteins can only come about through
the differential expression of key transcriptional networks which
based on the results of our functional enrichment analysis, clearly
affect a significant proportion of those genes found in the core
group. The fact that we did not see categories more specific to the
differentiation of promyelocytes into neutrophils may be because
these highly-specific terms usually sit at the periphery of the GO
Table 1. Enriched GO terms for the core group that were statistically significant at the 0.1 level.
GO ID
Number of
Core Genes
in GO Term
Total Number
of Core Genes
Total Number of
Transient Genes
Number of
Genes in
GO Term P-value
Adjusted
P-value Ontology GO Term
GO:0003676 358 1428 1462 618 1.08610
26 0.00833 MF Nucleic acid binding
GO:0016070 317 1428 1462 547 5.52610
26 0.0129 BP RNA metabolic process
GO:0044446 339 1428 1462 590 7.10610
26 0.0129 CC intracellular organelle part
GO:0044422 340 1428 1462 592 7.24610
26 0.0129 CC organelle part
GO:0044428 168 1428 1462 271 8.41610
26 0.0129 CC Nuclear part
GO:0006350 257 1428 1462 441 3.18610
25 0.0407 BP transcription
GO:0032774 234 1428 1462 400 5.46610
25 0.0460 BP RNA biosynthetic process
GO:0032991 271 1428 1462 470 5.60610
25 0.0460 CC macromolecular complex
GO:0006694 17 1428 1462 18 5.74610
25 0.0460 BP steroid biosynthetic process
GO:0006351 23 1428 1462 397 6.53610
25 0.0460 BP transcription, DNA-dependent
GO:0006355 224 1428 1462 382 6.58610
25 0.0460 BP regulation of transcription, DNA-dependent
GO:0045449 239 1428 1462 413 0.000124 0.0792 BP regulation of transcription
GO:0006139 430 1428 1462 782 0.000152 0.0902 BP nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process
doi:10.1371/journal.pcbi.1000626.t001
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functional classes. Therefore, it is less likely to see enrichment
given the starting pool of genes retained by the filtering
procedures. For example, neutrophil differentiation class has five
gene products, regulation of neutrophil differentiation class has
two gene products in the current version of GO.
The enriched GO functional classes in the transient group,
relative to the core group, showed compelling evidence in line with
our assumption that transient genes are primarily involved in
perturbation-related processes only. We identified seven enriched
GO functional classes, and all seven collectively describe typical
cellular responses to an external perturbation (see Table 2). For
instance, ‘‘defense response’’, ‘‘response to external stimulus’’,
‘‘response to wounding’’ (defined as ‘‘A change in state or activity
of a cell or an organism (in terms of movement, secretion, enzyme
production, gene expression, etc.) as a result of a stimulus
indicating damage to the organism.’’) and ‘‘response to stimulus’’,
‘‘inflammatory response’’ (defined as ‘‘The immediate defensive
reaction (by vertebrate tissue) to infection or injury caused by
chemical or physical agents.’’) are exactly the kind of functional
classes we would expect to see based on our definition of the
transient gene group. The remaining two classes ‘‘signal
transduction’’ and ‘‘cell communication’’ describe processes that
are directly triggered by an inducer.
Specific Biological Examples
As a further validation step of our proposed model, we utilize
the information known about the induction pathways of DMSO
and ATRA in HL-60 cells since we expect these genes whose
expression is regulated by these pathways to be in the transient
group. The proteins PTEN, Akt1, p27 play an integral role in the
signaling pathways triggered directly by DMSO [15,16] (see
Table 2. Enriched GO terms for the transient group that were statistically significant at the 0.1 level.
GO ID
Number of Core
Genes in GO Term
Total Number of
Transient Genes
Total Number
of Core Genes
Number of Genes
in GO Term P-value
Adjusted
P-value Ontology GO Term
GO:0006952 99 1462 1428 137 1.02610
27 0.000471 BP defense response
GO:0009605 92 1462 1428 126 1.32610
27 0.000471 BP response to external stimulus
GO:0009611 73 1462 1428 96 1.84610
27 0.000471 BP response to wounding
GO:0006954 60 1462 1428 77 5.42610
27 0.00104 BP inflammatory response
GO:0007165 373 1462 1428 638 3.89610
26 0.00542 BP signal transduction
GO:0050896 291 1462 1428 486 4.23610
26 0.00542 BP response to stimulus
GO:0007154 393 1462 1428 679 8.24610
26 0.00906 BP cell communication
doi:10.1371/journal.pcbi.1000626.t002
Figure 2. DMSO signaling pathway. DMSO upregulates the tumor suppressor protein PTEN [15] in HL-60 cells. This increase in PTEN expression
and activity is brought about by the activation of NF-kB. PTEN is a lipid phosphatase that is located in the cytoplasm and one of its primary roles is to
dephosphorylate PIP3, a product of PI3K. The upregulation of PTEN results in a perturbation of the PI3k/Akt pathway, specifically the reduction in Akt
phosphorylation levels and hence decreasing the amount of activated Akt. Normally activated Akt leads to phosphorylation of FOXO3, a member of
the forkhead transcription factor family and this sets off further pathways that promote cell survival. However, inactive FOXO3 is able to translocate to
the nucleus where it acts as a transcription factor, binding to cis-DNA elements and causing an increase in the gene expression of p27 [16]. The p27
protein inhibits the cyclin-dependent kinase complex Cyclin E and CDK2 which controls the G1 to S phase transition.
doi:10.1371/journal.pcbi.1000626.g002
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are known to be differentially expressed by DMSO. PTEN and
Akt were classified as transient genes by our model.
Similarly, we saw key ATRA-induced genes: RXR-a, p21,
CITED2, RARRES3, MBN, CD38 and SMYD5 featured in the
transient group [18–23] (see Figures 3 and S3 [17]). CITED2 is
the CREB binding protein/p300 complex that is a transcriptional
activator that is induced by ATRA [18]. RARRES3 is one of three
known genes that respond to the synthetic retinoid tazarotene, a
common treatment for dermatological diseases (the other two
genes do not feature in our data). The myeloblastin gene (MBN) is
known to be down-regulated during RA-induced differentiation of
HL-60 cells. MBN is a serine proteinease, also called Proteinase-3.
SMYD5 is a member of the SMYD family and its expression also
responds to RA induction [19]. HL-60 cells normally do not
express the cell surface antigen CD38, but when exposed to
ATRA, these cells undergo an immunophenotypic transition to
become CD38+ [20].
In surveying the literature, we were able to identify a total of ten
genes whose expression levels have been reported to be induced by
either DMSO or ATRA. This includes three induced by DMSO
(Akt, p27, PTEN) and seven by ATRA (RXR-a, p21, CITED2,
RARRES3, MBN, CD38, SMYD5). Of these ten, only one (p27)
was not identified as belonging to the transient group using our
approach. Therefore, observing nine out of ten inducer-related
genes in the transient group was a statistically significant result
with a P-value of 0.0117 (Fisher’s exact test, see Text S2 [17]).
Our model also predicts that key genes involved in the
differentiation of promyelocytes should feature in the core group.
We took the set of sixteen genes identified by two papers that studied
the myeloid-specific differentiation pathways in HL-60 cells; these
genes belonged to the Myc, Mad,Bcl-2 and Caspase families [24,25]
(see Figure S4 [17]). Thirteen out of sixteen were classified as core
genes. This result was highly significant with a P-value of 0.00924,
The Myc proteins are a family of transcription factors that
regulate important cellular processes like proliferation, apoptosis
and differentiation. HL-60 cells are naturally in a proliferative
state, however in the presence of an inducer like ATRA or
DMSO, the transition to enter the differentiation pathway is
brought about by Myc and Mad [24]. Myc, specifically c-myc is
abundant in proliferating HL-60 cells, but its downregulation is
associated with differentiating HL-60 cells. Mad is a family of
mitotic checkpoint genes and their expression prevents a cell from
completing the cell cycle. Mad1 mRNA transcripts are highly
expressed in differentiating HL-60 cells but undetectable in
proliferating cells. Members of the Myc family and the Mad
family with expression data available were: c-Myc, Myc binding
protein 2 (a nuclear protein that binds specifically to Myc) [26] and
Mad2. These three genes were in our core group.
Upon differentiation, HL-60 cells undergo apoptosis [25]. To
this end, HL-60 cells are known to downregulate genes in the Bcl-2
family which promotes cell survival, and upregulate genes in the
caspase family which mediate cell death. Expression data was
available for the following Bcl-2 genes: Bcl-2, Bfl-1 (BCL2A1), Bik,
Bcl-w (BCL2L2), Bax, BCLAF1 (Bcl2-associated transcription
factor 1); and for the following caspase genes: Caspase-1, Caspase-
2, Caspase-3, Caspase-6, Caspase-8, Caspase-9, Caspase-10. All
the Bcl-2 genes were in the core group, except for Bik. Five out of
the seven caspases were in the core group, while Caspase-1 and
Caspase-3 were in the transient group. Having 10 out of the 13
apoptosis-related genes in the core group also represented a
statistical significant enrichment (Fisher’s exact P-value 0.0418).
Figure 3. ATRA signaling pathway. ATRA is able to diffuse freely across the cell membrane. A pair of cellular retinoic acid binding proteins act as
cell surface receptors for retinoids however these have been shown to be dispensable in retinoic-acid signaling [21]. ATRA binds to a family of nuclear
hormone receptors called retinoic-acid receptors (RARs). There are three subtypes of the RAR family, these are encoded by different genes and
denoted RAR-a, RAR-b, RAR-c. Collins et al [22] demonstrated that in HL-60 cells, ATRA induced granulocytic differentiation by binding RAR-a directly.
RAR-a binds to specific cis-acting DNA sites, known as retinoic-acid response elements (RAREs). These RAREs are located in the promoter sequences
of specific genes that are targets of RAR-a. In order to bind DNA efficiently, RARs must however form heterodimers with a second family of nuclear
hormone receptors, the retinoid X receptors (RXRs), of which there are three subtypes: RXR-a, RXR-b, RXR-c. Both RXRs and RARs function as ligand-
dependent transcription factors. One of the RAR-target genes whose expression is upregulated is the cell cycle protein p21 [23]. p21 inhibits the
cyclin dependent kinase complex Cyclin E and CDK2. In this way, ATRA induces cell cycle arrest at the G1 to S phase transition checkpoint.
doi:10.1371/journal.pcbi.1000626.g003
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ATRA signaling in HL-60 cells, we know that the point at which
these pathways converge is at the G1-S phase transition point
controlled by the cyclin dependent kinase complex of Cyclin E and
CDK2. The genes that encode Cyclin E and CDK2 were both
placed in the core group.
By pulling out known genes that play a critical role in the
DMSO and ATRA signaling pathways we see that most of these
genes are in the transient group. Similarly the majority of the
sixteen genes in the myeloid differentiation pathway were in the
core group. These examples provide further evidence to support
our explanation that underlying these cell fate transitions, there is
an interplay between a transient pathway and a core pathway that
involves those genes that regulate inducer-specific and differenti-
ation-specific processes, respectively. One limiting factor in our
analysis was the restriction imposed by the starting pool of 3841
genes retained from filtering steps applied by Huang et al [3].
There were several canonical genes (such as RAR-a, Mad1) that
were not in this group of 3841 genes and therefore were not
included in the downstream analyses.
Expression Trajectories
Visualization of the gene expression changes as they occur over
the duration of the time-course shows how this overall signal can
be decomposed into the transient and differentiation-specific
components. We constructed heatmap representations of the
trajectories using the visualization software tool GEDI ([27], see
Figure S5 [11]). This tool displays dominant patterns in high
dimensional gene expression data by applying a self-organizing
map (SOM) clustering algorithm and then creating mosaic tiles
which are colored according to a map that represents the centroid
values of each gene cluster. In this way, mosaics can be
constructed for each time point or each sample in the experiment,
and the expression pattern changes occurring across the
experiment are visually highlighted.
Figure 4 shows the heatmap representation for the separate
trajectories formed for the core and transient groups and the
overall group of 2980 genes. The SOM used by the GEDI tool
had a grid of 25 rows and 26 columns. On average, each tile
contains about 5 genes for the overall group and about 3 genes for
the core and transient component groups. We can see how the
overall trajectory initially displays divergence between the ATRA
and DMSO signal. After 2 days however, the trajectory begins to
converge. The transient group trajectory displays heatmaps that
for the DMSO and ATRA signal are almost inverted, mirror
images of each other. The core group trajectory on the other hand
displays heatmaps that have highly similar structures for DMSO
and ATRA for the duration of the time-course. We also
constructed the core and transient-specific components of the
gene expression trajectories using principal component analysis
(see Figure S6 [17]).
Discussion
Using the HL-60 cell line as an example, we note that the main
molecular outcome of the two inducers DMSO and ATRA, is to
arrest the cell cycle at the G1-S phase transition point. DMSO
exerts this effect ultimately by increasing the expression of p27
whereas ATRA upregulates the expression of p21. Both of these
proteins p27 and p21 block the cyclin dependent kinase complex
Cyclin E and CDK2 which normally drives the cell cycle past this
transition point. HL-60 cells are therefore stimulated to converge
to a state where both cell populations exhibit the genome-wide
gene expression profiles associated with an arrested cell cycle (and
thereby the differentiation profiles associated with neutrophil-like
cells), however it is important to point out that this convergence is
an eventual result of the molecular effects exerted by the inducers.
This convergence only emerges later in the time-course because
these inducers have different biochemical means of initially getting
to the core differentiation pathway. By recognizing this interplay
between the two types of processes that are driving cell fate
Figure 4. Gene expression mosaics of the ATRA and DMSO-stimulated time course data. The expression mosaics for the ATRA and DMSO-
stimulated time course data capture spatial patterns in the data as the system iterates through the time series. These images are a graphical
representation of dynamic expression changes in the data, clustered using a self-organizing map algorithm (SOM). We show how the overall
expression trajectories for the ATRA and DMSO-stimulated data can be divided into components defined by the core and transient set of genes. Red
denotes extreme positive log expression ratios, blue denotes extreme negative log expression ratios.
doi:10.1371/journal.pcbi.1000626.g004
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solid link between our knowledge of key molecular events
occurring in this system with the convergent properties of these
trajectories that we are observing.
Attempts to reconcile the attractor hypothesis with an equally
robust explanation that appeals to molecular biology are difficult
and reveal some of the limitations of the attractor hypothesis.
Specifically, it does not afford the mechanistic interpretation that
the core/transient profile decomposition does. While it is worth
noting that the temporal damping of the transient and core
differentiation gene expression levels is consistent with what one
would expect in the case of an attractor, the attractor hypothesis in
its simplest form suggests that there should be a large class of
perturbations that displace a biological system from its initial state,
initiating the transition to its final state. This is in stark contrast to
what we observe biologically [28].
The resolution to this apparent contradiction may be that the
landscape of the gene expression state space is much more
complex and ‘‘rugged’’ than most simple models assume. Conrad
Waddington first proposed the notion of ‘‘canalization’’ (essential-
ly, the existence of canal-like routes) in describing cell fate
transitions to describe what he saw as a relatively small number of
allowable state space trajectories connecting initial and final cell
states [8]. Waddington used the analogy of water flowing down a
hill via a series of valleys which correspond to these canalized
paths which would, by their nature, be robust to small
perturbations. In much the same way, the core and transient
components suggested by our trajectory model can be thought of
as being a ‘‘core’’ component equivalent to the central pathway
between states with the transient components representing
orthogonal perturbations relative to the core downhill pathways.
In such a model, one could imagine selective pressure over time
defining the canals as particular pathways become increasingly
essential to allow transitions to well-defined cellular states. In such
a model, one could argue that the development of undifferentiated
states, such as those which develop in cancer, arise when the canals
are destroyed or significantly altered. In any event, the overall
effect of this combination of core and transient components is that
differentiation pathways are buffered against perturbations but are
still able to mediate apparently deterministic transitions between
phenotypes.
It may be argued that by our definition of what makes a core
and a transient process, we are entering a circular argument and
imposing structural properties on the trajectory components that
we originally hypothesized we might see. For example, because
core genes are defined as those whose expression profiles remain
invariant for different inducers, we would consequently expect that
the core trajectories for two inducers to have similar shapes, and
the transient trajectories would be less comparable. We acknowl-
edge that this is somewhat true, however we believe that the true
power of our approach lies in the framework that it provides in
allowing us to deconvolute high-throughput data on perturbed
networks. By being able to resolve the transient, perturbation-
driven processes from the core pathways, this approach gives us a
means to compare the effects of different perturbations on a
systems-level.
For example, in a situation where a chemotherapeutic drug
results in differential remission rates amongst patients, we may
begin to explore how this same perturbation applied to multiple
patients affects these transient and core components. The current
framework also provides a means to extend this model to explicitly
acknowledge the role stochastic processes play in the cell. We
could model the trajectory components as realizations of a
stochastic process and construct an appropriate probability
distribution or density function that describes this process. Such
a model allows for deviations from the most likely route and
consequently allows for changes that could lead to the transition
from normal cells to the development of disease states. Such
models would have applications in understanding the development
of disease states such as APL or in understanding systems-level
evolution of phenotypic responses such as drug resistance. Using
our probability distribution model, we could make predictions of
the most likely trajectory a cellular system will take in
consideration of external cues or microenvironment properties of
the system.
Methods
Annotation Sources
We made use of the mappings to GO categories and KEGG
pathways from the latest version at the time of the Bioconductor
annotation package hgu95av2 (version 2.0.1).
Data Availability
The full set of expression data is made publicly available
through GEO (accession identifier: GSE14500). The expression
data for the 3841 genes can be downloaded as a supplemental file
(Dataset S1) and is also made available from our website [11].
Supporting Information
Dataset S1 This file contains the gene expression data for the
3841 genes that were retained after filters were applied to remove
genes that were associated with low expression or did not show
significant expression changes across the time points measured.
The expression measures in the data set provided by Huang et al.
[3] are represented as normalized log2 expression ratio values
where each gene’s ratio is formed by comparing its expression
measure in the stimulated time-course to its corresponding
expression in a non-stimulated control sample of HL-60 cells.
Found at: doi:10.1371/journal.pcbi.1000626.s001 (1.35 MB XLS)
Figure S1 CD4 is an example of a gene with a spiky expression
profile and our model does a limited job at predicting the
expression levels observed. However, the purpose of our model is
not to predict expression but to estimate parameters that lets us
determine whether a particular gene belongs in the core or
transient group within a robust statistical framework that gives us
the means to adjust for false positives and multiple testing issues.
Found at: doi:10.1371/journal.pcbi.1000626.s002 (0.02 MB PDF)
Figure S2 Expression profiles for some genes involved in
DMSO-induced signaling.
Found at: doi:10.1371/journal.pcbi.1000626.s003 (0.03 MB PDF)
Figure S3 Expression profiles for some genes involved in
ATRA-induced signaling.
Found at: doi:10.1371/journal.pcbi.1000626.s004 (0.03 MB PDF)
Figure S4 Expression profiles for some genes known to
participate in myeloid differentiation.
Found at: doi:10.1371/journal.pcbi.1000626.s005 (0.03 MB PDF)
Figure S5 Gene expression trajectories and their core and
transient sub-components for the DMSO and ATRA-stimulated
data.
Found at: doi:10.1371/journal.pcbi.1000626.s006 (0.02 MB PDF)
Figure S6 Cartoon describing how Figure 3 was constructed
using GEDI software.
Found at: doi:10.1371/journal.pcbi.1000626.s007 (0.02 MB PDF)
Decomposition of State Space Trajectories
PLoS Computational Biology | www.ploscompbiol.org 9 December 2009 | Volume 5 | Issue 12 | e1000626Table S1 The core genes. Table S1 lists the 1428 genes that
were placed in the core group.
Found at: doi:10.1371/journal.pcbi.1000626.s008 (0.06 MB PDF)
Table S2 The transient genes. Table S2 lists the 1462 genes that
were placed in the transient group.
Found at: doi:10.1371/journal.pcbi.1000626.s009 (0.06 MB PDF)
Text S1 The Likelihood Ration Test. Text S1 contains
information on how the likelihood ratio test and the analysis of
deviance test are computed from the data. This section includes an
example using expression data for a gene to show how our method
uses these tests to places genes in the core and transient groups.
Found at: doi:10.1371/journal.pcbi.1000626.s010 (0.04 MB PDF)
Text S2 Using Fisher’s exact test. Text S2 outlines how we use
the Fisher’s exact test to compute the significance of seeing an
enrichment of transient or core genes in sets of genes extracted
from the literature.
Found at: doi:10.1371/journal.pcbi.1000626.s011 (0.02 MB PDF)
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